[1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019—COVID-19. Clinical Microbiology Reviews. 2020;33: e00028–e00020.10.1128/CMR.00028-20]Search in Google Scholar
[2. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, Mcginn T, Davidson KW. Presenting characteristics, comorbidities and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323: 2052–2059.10.1001/jama.2020.6775]Search in Google Scholar
[3. Huang C, Wang Y, Li X, Ren Li, Zhao J, Hu Yi, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223): 497–506.10.1016/S0140-6736(20)30183-5]Search in Google Scholar
[4. Ministry of Health & Family Welfare, Government of India. Revised guidelines on clinical management of COVID-19. Available from: https://www.mohfw.gov.in/pdf/RevisedNational-ClinicalManagementGuidelineforCOVID1931032020.pdf [Accessed 20th June 2020].]Search in Google Scholar
[5. World Health Organization. Clinical management of COVID-19. Available from: https://www.who.int/publicationsdetail-redirect/clinical-anagement-of-covid-19 [Accessed 22nd November 2020].]Search in Google Scholar
[6. Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Clinical management of COVID-19. Indian Journal of Medical Research. 2020;151(5): 401–410.10.4103/ijmr.IJMR_957_20753043532611911]Search in Google Scholar
[7. Indian Council of Medical Research. Available from: https://main.icmr.nic.in/content/covid-19 [Accessed 22nd November 2020].]Search in Google Scholar
[8. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England Journal of Medicine. 2000;342: 1301–1308.10.1056/NEJM20000504342180110793162]Search in Google Scholar
[9. Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Archives for Chest Disease. 2020;90: 1294.10.4081/monaldi.2020.129432290644]Search in Google Scholar
[10. Pande D, Kochhar A, Saini S, Ganapathy U, Gogia AR. An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian Journal of Palliative Care. 2020;26(Suppl S1): 36–39.10.4103/IJPC.IJPC_146_20753498233088084]Search in Google Scholar
[11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11): 1061–1069.10.1001/jama.2020.1585704288132031570]Search in Google Scholar
[12. Budhiraja S, Soni A, Jha V, Indrayan A, Dewan A, Singh O, et al. Clinical profile of first 1000 COVID-19 cases admitted at tertiary care hospitals and the correlates of their mortality: an Indian experience. medRxiv. 2020.11.16.20232223. Available from: doi:10.1101/2020.11.16.20232223.10.1101/2020.11.16.20232223]Search in Google Scholar
[13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18): 1708–1720.10.1056/NEJMoa2002032709281932109013]Search in Google Scholar
[14. Kaur N, Gupta I, Singh H, Karia R, Ashraf A, Habib A, et al. Epidemiological and clinical characteristics of 6635 COVID-19 patients: a pooled analysis. SN Comprehensive Clinical Medicine. 2020;9: 1–5. Available from: doi:10.1007/s42399-020-00393-y.10.1007/s42399-020-00393-y734340732838160]Search in Google Scholar
[15. Aggarwal A, Shrivastava A, Kumar A, Ali A. Clinical and epidemiological features of SARS-CoV-2 patients in SARI ward of a tertiary care centre in New Delhi. Journal of the Association of Physicians of India. 2020;68(7): 19–26.]Search in Google Scholar
[16. Tian S, Liu H, Liao M, Wu Y, Yang C, Cai Y, et al. Analysis of mortality in patients With COVID-19: clinical and laboratory parameters. Open Forum Infectious Diseases. 2020;7(5): ofaa152.10.1093/ofid/ofaa152719755632457924]Search in Google Scholar
[17. Saluja M, Pillai D, Jeliya S, Bauddh N, Chandel R. COVID 19-clinical profile, radiological presentation, prognostic predictors, complications and outcome: A perspective from the Indian sub-continent. Journal of the Association of Physicians of India. 2020;68(7): 13–18.]Search in Google Scholar
[18. Bhatraju PK, Ghassemeih BJ, Nichols M, Kim R, Jierome KR, Nalla AK, et al. Covid-19 in critically Ill patients in the Seattle Region – Case series. The New England Journal of Medicine. 2020;382: 2012–2022.10.1056/NEJMoa2004500714316432227758]Search in Google Scholar
[19. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-cov-2 in Wuhan, China. Allergy. 2020;75(7): 1730–1741.10.1111/all.1423832077115]Search in Google Scholar
[20. Bhandari S, Bhargava A, Sharma S, Keshwani P, Sharma R, Banerjee S. Clinical profile of Covid-19 infected patients admitted in a tertiary care hospital in North India. Journal of the Association of Physicians of India. 2020;68(5): 13–17.]Search in Google Scholar
[21. Shrestha DB, Budhathoki P, Syed N, Rawal E, Raut S, Khadka S. Remdesivir: A potential game changer or just a myth? A systematic review and meta-analysis. Life Sciences. 2020;26: 118663. doi: 10.1016/j.lfs.2020.118663.10.1016/j.lfs.2020.118663758610533121991]Search in Google Scholar
[22. Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N, Rashmi P. Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis. Virology Journal. 2020;17: 141.10.1186/s12985-020-01412-z751221832972430]Search in Google Scholar
[23. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective. Diabetology & Metabolic Syndrome. 2020;14(5): 971–978.10.1016/j.dsx.2020.06.054732071332610262]Search in Google Scholar
[24. Focosi D, Anderson AO, Tang JW, Tuccori M. Convalescent plasma therapy for COVID-19: state of the art. Clinical Microbiology Reviews. 2020;33(4): e00072-20.10.1128/CMR.00072-20743029332792417]Search in Google Scholar
[25. Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo Am, Garcia Ch, et al. Repurposed antiviral drugs for COVID-19 – interim WHO SOLIDARITY trial results. WHO Solidarity Trial Consortium. The New England Journal of Medicine. 2021;384:497–511.]Search in Google Scholar
[26. Fu L, Li XY, Fei J, Xiang Y, Xiang HX, Li MD, et al. Myocardial injury at early stage and its association with the risk of death in COVID-19 patients: A Hospital-Based Retrospective Cohort Study. Frontiers in Cardiovascular Medicine. 2020;7: 590688.10.3389/fcvm.2020.590688766163633195480]Search in Google Scholar
[27. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American College of Cardiology. 2020;75(23): 2950–2973. Available from: doi:10.1016/j.jacc.2020.04.031.10.1016/j.jacc.2020.04.031716488132311448]Search in Google Scholar
[28. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369: m1985.10.1136/bmj.m1985724303632444460]Search in Google Scholar
[29. Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian Journal of Medical Research. 2020;152(1 & 2): 61–69.10.4103/ijmr.IJMR_1788_20785326032773414]Search in Google Scholar
[30. Xie J, Wu W, Li S, Hu Y, Hu M, Li J, et al. Clinical characteristics and outcomes of critically ill patients with novel corona-virus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Medicine. 2020;46(10): 1863–1872.10.1007/s00134-020-06211-2743924032816098]Search in Google Scholar